Expression of ADAMTS1 and Its Correlation with Angiogenesis in Primary Gastric Cancer and Lymph Node Metastasis

详细信息    查看全文

• 作者：Jing Chen (1)
  Yu Zhi (1)
  Xiaojing Chang (1)
  Shuanglong Zhang (1)
  Dongqiu Dai (1)
  
• 关键词：ADAMTS1 ; TSP1 ; VEGF ; Gastric cancer ; Metastatic lymph node
• 刊名：Digestive Diseases and Sciences
• 出版年：2013
• 出版时间：February 2013
• 年：2013
• 卷：58
• 期：2
• 页码：405-413
• 全文大小：601KB
• 参考文献：1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. / CA Cancer J Clin. 2005;55:74-08. CrossRef
  2. Kodama M, Kitadai Y, Tanaka M, et al. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. / Clin Cancer Res. 2008;14:7205-214. CrossRef
  3. Traxler P, Allegrini PR, Brandt R, et al. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. / Cancer Res. 2004;64:4931-941. CrossRef
  4. Shin VY, Wu WK, Chu KM, et al. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. / Mol Cancer Res. 2005;3:607-15. CrossRef
  5. Zhang J, Ding J, Zhang X, Shao X, Hao Z. Regulation of vascular endothelial growth factor (VEGF) production and angiogenesis by tissue Factor (TF) in SGC-7901 gastric cancer cells. / Cancer Biol Ther. 2005;4:769-72. CrossRef
  6. Tanigawa N, Amaya H, Matsumura M, et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. / Cancer Res. 1996;56:2671-676.
  7. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. / Clin Cancer Res. 1996;2:1679-684.
  8. Luque A, Carpizo DR, Iruela-Arispe ML. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. / J Biol Chem. 2003;278:23656-3665. CrossRef
  9. Kaushal GP, Shah SV. The new kids on the block: ADAMTSs, potentially multifunctional metalloproteinases of the ADAM family. / J Clin Invest. 2000;105:1335-337. CrossRef
  10. Tang BL, Hong W. ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. / FEBS Lett. 1999;445:223-25. CrossRef
  11. Colige A, Sieron AL, Li SW, et al. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. / Am J Hum Genet. 1999;65:308-17. CrossRef
  12. Glasson SS, Askew R, Sheppard B, et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. / Arthritis Rheum. 2004;50:2547-558. CrossRef
  13. Masui T, Hosotani R, Tsuji S, et al. Expression of METH-1 and METH-2 in pancreatic cancer. / Clin Cancer Res. 2001;7:3437-443.
  14. Llamazares M, Obaya AJ, Moncada-Pazos A, et al. The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway. / J Cell Sci. 2007;120:3544-552. CrossRef
  15. Porter S, Scott SD, Sassoon EM, et al. Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. / Clin Cancer Res. 2004;10:2429-440. CrossRef
  16. Dunn JR, Panutsopulos D, Shaw MW, et al. METH-2 silencing and promoter hyper methylation in NSCLC. / Br J Cancer. 2004;91:1149-154.
  17. Keightley MC, Sales KJ, Jabbour HN. PGF2alpha-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer. / BMC Cancer. 2010;10:488. CrossRef
  18. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. / Nature. 2001;413:488-94. CrossRef
  19. Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. / Cancer Sci. 2007;98:621-28. CrossRef
  20. Jones GC, Riley GP. ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. / Arthritis Res Ther. 2005;7:160-69. CrossRef
  21. Sandy JD, Westling J, Kenagy RD, et al. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. / J Biol Chem. 2001;276:13372-3378. CrossRef
  22. Russell DL, Doyle KM, Ochsner SA, Sandy JD, Richards JS. Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation. / J Biol Chem. 2003;278:42330-2339. CrossRef
  23. Kuno K, Bannai K, Hakozaki M, Matsushima K, Hirose K. The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential. / Biochem Biophys Res Commun. 2004;319:1327-333. CrossRef
  24. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. / J Biol Chem. 1997;272:556-62. CrossRef
  25. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. / Nature. 2000;407:242-48. CrossRef
  26. Kodama J, Hashimoto I, Seki N, et al. Thrombospondin-1 and -2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis. / Clin Cancer Res. 2001;7:2826-831.
  27. Dawson DW, Volpert OV, Pearce SF, et al. Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat. / Mol Pharmacol. 1999;55:332-38.
  28. Choi JE, Kim DS, Kim EJ, et al. Aberrant methylation of ADAMTS1 in non-small cell lung cancer. / Cancer Genet Cytogenet. 2008;187:80-4. CrossRef
  29. Gustavsson H, Wang W, Jennbacken K, Welen K, Damber JE. ADAMTS1, a putative anti-angiogenic factor, is decreased in human prostate cancer. / BJU Int. 2009;104:1786-790. CrossRef
  30. Liu YJ, Xu Y, Yu Q. Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively. / Oncogene. 2006;25:2452-467. CrossRef
  31. Rocks N, Paulissen G, Quesada-Calvo F, et al. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. / Cancer Res. 2008;68:9541-550. CrossRef
  32. Zhi Y, Chen J, Zhang S, Chang X, Ma J, Dai D. Down-regulation of CXCL12 by DNA hypermethylation and its involvement in gastric cancer metastatic progression. / Dig Dis Sci. 2012;57:650-59. CrossRef
  33. Yu LF, Cheng Y, Qiao MM, Zhang YP, Wu YL. Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor. / World J Gastroenterol. 2005;11:875-79.
  34. Kim J, Kim C, Kim TS, et al. IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. / Biochem Biophys Res Commun. 2006;344:1284-289. CrossRef
  35. Nakao T, Kurita N, Komatsu M, et al. Expression of thrombospondin-1 and Ski are prognostic factors in advanced gastric cancer. / Int J Clin Oncol. 2011;16:145-52. CrossRef
  36. Oh SY, Kwon HC, Kim SH, et al. Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer. / BMC Cancer. 2008;8:123. CrossRef
  37. Rocks N, Paulissen G, Quesada CF, et al. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes inhuman non-small-cell lung carcinomas (NSCLC). / Br J Cancer. 2006;94:724-30.
  38. Lind GE, Kleivi K, Meling GI, et al. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. / Cell Oncol. 2006;28:259-72.
  39. Lu X, Wang Q, Hu G, et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. / Genes Dev. 2009;23:1882-894. CrossRef
  40. Esselens C, Malapeira J, Colome N, et al. The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration. / J Biol Chem. 2010;285:2463-473. CrossRef
  41. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. / Cancer Cell. 2003;3:537-49. CrossRef
  42. Demircan K, Gunduz E, Gunduz M, et al. Increased mRNA expression of ADAMTS metalloproteinases in metastatic foci of head and neck cancer. / Head Neck. 2009;31:793-01. CrossRef
  43. Vazquez F, Hastings G, Ortega MA, et al. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. / J Biol Chem. 1999;274:23349-3357. CrossRef
  44. Lee NV, Sato M, Annis DS, et al. ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. / EMBO J. 2006;25:5270-283. CrossRef
  45. Gustavsson H, Tesan T, Jennbacken K, Kuno K, Damber JE, Welen K. ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors. / BMC Cancer. 2010;10:288. CrossRef
  46. Lee YJ, Koch M, Karl D, et al. Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1. / Cancer Res. 2010;70:948-56. CrossRef
  
• 作者单位：Jing Chen (1)
  Yu Zhi (1)
  Xiaojing Chang (1)
  Shuanglong Zhang (1)
  Dongqiu Dai (1)
  
  1. Department of Gastrointestinal Surgery, Fourth Affiliated Hospital, China Medical University, Chongshan East Road 4, Shenyang, 110032, Liaoning, China
  
• ISSN：1573-2568

文摘

Background A disintegrin and metallopeptidase with thrombospondin motif type 1 (ADAMTS1) is a recently discovered metalloproteinase with antiangiogenic activity. The function of ADAMTS1 in gastric cancer remains unknown. Therefore, we were interested in examining ADAMTS1 expression in human gastric cancer, as well as its possible correlation with angiogenesis. Methods The mRNA and protein expression of ADAMTS1, thrombospondin type I (TSP1), and vascular endothelial growth factor (VEGF) was evaluated by RT-PCR and immunohistochemistry, respectively, in 56 paired tumor and normal tissue samples, and corresponding metastatic lymph nodes (n?=?42). Microvessel density (MVD) was also evaluated by immunohistochemistry. Results ADAMTS1 mRNA and protein levels were significantly lower in primary tumors than in corresponding normal tissues, and were significantly higher in metastatic lymph nodes compared to their matched primary tumors. High ADAMTS1 mRNA and protein expression was found to be significantly associated with lymph node metastasis in primary tumors. There was a negative correlation between ADAMTS1 and VEGF mRNA and protein expression in primary gastric tumors and normal tissues. A negative correlation was also found between ADAMTS1 protein expression and MVD in primary gastric tumors. In contrast, no correlation was detected between ADAMTS1 and TSP1 mRNA and protein expression in primary gastric tumors, normal tissues, and metastatic lymph nodes. Conclusions These findings suggest that ADAMTS1 expression is altered in primary gastric cancer and paired lymph node metastasis. In addition, ADAMTS1 has angioinhibitory effects in primary gastric cancer due to its low expression and negative correlation with VEGF and MVD. However, it appears to lose its anti-angiogenic activity in metastatic lymph nodes in gastric cancer.